CSF Neopterin and Beta-2-microglobulin As Inflammation Biomarkers in Newborns with Hypoxic-ischemic Encephalopathy
Overview
Affiliations
Background: Inflammation plays a crucial role in the pathogenesis of hypoxic-ischemic encephalopathy (HIE). The aim of this study was to measure inflammation in HIE through an analysis of CSF neopterin and β2-microglobulin and to study the association with brain injury as shown by MRI findings and neurodevelopmental outcomes.
Methods: CSF biomarkers were measured in study patients at 12 and 72 h. Brain injury was evaluated by MRI, and neurodevelopmental outcomes were assessed at 2-3 years of life. An adverse outcome was defined as the presence of motor or cognitive impairment.
Results: Sixty-nine HIE infants were included. Median values of neopterin and β2-microglobulin paralleled the severity of HIE. Adverse outcomes were associated with early neopterin and β2-microglobulin values, late neopterin values, and the neopterin percentage change between the two samples. A cutoff value of 75% neopterin change predicted adverse outcomes with a specificity of 0.9 and a sensitivity of 0.75.
Conclusions: CSF neopterin and β2-microglobulin are elevated in HIE, indicating the activation of inflammation processes. Infants with adverse neurodevelopmental outcomes show higher levels of CSF neopterin and β2-microglobulin. The evolution of neopterin levels provides a better predictive capacity than a single determination.
Impact: Brain inflammation in newborns with HIE could be measurable through the analysis of CSF neopterin and β2-microglobulin, both of which are associated with neurodevelopmental outcomes. Our study introduces two inflammatory biomarkers for infants with HIE that seem to show a more stable profile and are easier to interpret than cytokines. CSF neopterin and β2-m may become clinical tools to monitor inflammation in HIE and might eventually be helpful in measuring the response to emerging therapies.
Tan J, Fang H, Hu X, Yue M, Yang J Front Mol Biosci. 2024; 11:1476080.
PMID: 39633986 PMC: 11614729. DOI: 10.3389/fmolb.2024.1476080.
Zhang D, Li D, Wang X, Sui Y, Ma F, Dai Y Cell Mol Neurobiol. 2024; 44(1):49.
PMID: 38836960 PMC: 11153299. DOI: 10.1007/s10571-024-01483-4.
The Role of Beta2-Microglobulin in Central Nervous System Disease.
Liu Z, Tang F, Yang J, Chen X, Wang Z, Li Z Cell Mol Neurobiol. 2024; 44(1):46.
PMID: 38743119 PMC: 11093819. DOI: 10.1007/s10571-024-01481-6.
Liu Y, Pan J, Pan X, Kong F, Zhang J, Wei Z Invest Ophthalmol Vis Sci. 2024; 65(1):13.
PMID: 38175639 PMC: 10774692. DOI: 10.1167/iovs.65.1.13.
Shen Y, Chen J, Yao W, Feng S, Yang H, Chen D J Thorac Dis. 2023; 15(9):4914-4924.
PMID: 37868894 PMC: 10586954. DOI: 10.21037/jtd-23-1185.